Abstract A92: Aminomethylphosphonic acid inhibits human prostate xenograft tumor growth through interfering glycine synthesis in the cancer cells

In conclusion, we found that AMPA inhibits human prostate xenograft tumor growth through inducing apoptosis and inhibiting cellular proliferation, which suggests that AMPA may be developed into a new treatment for prostate cancer.Citation Format: Keshab R. Parajuli, Qiuyang Zhang, Sen Liu, Zongbing You. Aminomethylphosphonic acid inhibits human prostate xenograft tumor growth through interfering glycine synthesis in the cancer cells. [abstract]. In: Proceedings of the AACR Special Conference: Metabolism and Cancer; Jun 7-10, 2015; Bellevue, WA. Philadelphia (PA): AACR; Mol Cancer Res 2016;14(1_Suppl):Abstract nr A92.

Source: Molecular Cancer Research - January 15, 2016 Category: Cancer & Oncology Authors: Parajuli, K. R., Zhang, Q., Liu, S., You, Z. Tags: Therapeutic Targets From Cancer: Poster Presentations - Proffered Abstracts Source Type: research